NEPH.NASDAQNephros INC

Form 4: Alisa Lask, Nephros Inc. Director, Reports Stock Option Grant

Sentiment:

SEC Filing

📋All filings for Nephros INC
🔒Login to Follow

Director Alisa Lask reports the acquisition of stock options in Nephros Inc.

Summary

  • Alisa Lask, a director of Nephros Inc., filed a Form 4 disclosing changes in beneficial ownership.
  • The report details the grant of stock options to Ms. Lask on May 14, 2024.
  • Ms. Lask now directly owns 48,629 shares of common stock.
  • She also holds options to purchase additional shares at various exercise prices and expiration dates.
  • The newly granted options vest in three annual installments starting May 14, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Positives

  • The grant of stock options to a director aligns their interests with those of the shareholders.
  • The vesting schedule encourages continued service on the board.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

  • The stock option grant aligns the director's interests with shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates

DateDescription
01/05/2023First vesting date for a portion of previously held stock options.
01/05/2024Second vesting date for a portion of previously held stock options.
05/14/2024Date of the stock option grant and first vesting date for the new options.
05/16/2024Date of Form 4 filing.
05/14/2025Second vesting date for the new stock options.
05/14/2026Third vesting date for the new stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.